BREAKING: President Donald Trump has signed an executive order aiming to cut U.S. prescription drug prices by aligning them with the lower prices paid in other developed countries, a move he claims could reduce costs by up to 59%. This “most favored nation” policy is designed to address the fact that Americans currently pay two to three times more for prescription drugs than people in other wealthy nations. The order instructs federal agencies to set price reduction targets within 30 days and, if negotiations with pharmaceutical companies fail, to enforce international reference pricing through regulation. The policy is a significant setback for the pharmaceutical industry
Discover how we can elevate your portfolio and deliver exceptional growth. NEW Monthly Payout Of At Least 0.5% In US Dollars
AlgoTrader 